SuperworthKeros Therapeutics market cap KROS
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Oct 23, 2026
- $223.7M
- Highest close in our data
- $2.8B
- Dec 2024
Keros Therapeutics is worth $223.7M at the close on Oct 23, 2026, at $11.28 a share.
That is down 63% over the last year and down 77% over five years.
Its highest close in our data was $2.8B in Dec 2024.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $223.7M | $199.1M | $584.9M | −65% |
| 2025 | $640.7M | $404.8M | $660.8M | −4% |
| 2024 | $665.1M | $665.1M | $2.8B | −44% |
| 2023 | $1.2B | $820.5M | $1.6B | −10% |
| 2022 | $1.3B | $660.5M | $1.6B | −3% |
| 2021 | $1.4B | $717.2M | $1.4B | −4% |
| 2020 | $1.4B | $544.8M | $1.6B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Keros Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| KROSKeros Therapeutics | $223.7M |
| NATRNatures Sunshine Products | $213.8M |
| ARVNArvinas | $477.3M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| LFVNLifevantage | $73.4M |
| COLLCollegium Pharmaceutical | $747.5M |
| SPROSpero Therapeutics | $64.6M |
| ABUSArbutus Biopharma | $831M |
| Peer median | $570.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Keros Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.